Clinical significance of subepithelial growth patterns in non-muscle invasive bladder cancer

BMC Urology

Volumn 11, Issue , 2011, Pages

  Miyake, Makito ^a   Hirao, Shuya ^a   Mibu, Hisakazu ^a   Tanaka, Masahiro ^b   Takashima, Kenji ^c   Shimada, Keiji ^d   Hirao, Kazuya ^a  

^a Hirao Hospital   (Japan)

^b Osaka Kaisei Hospital   (Japan)

^c Takashima Urologic Clinic   (Japan)

^d NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

bladder cancer; endophytic growth pattern; infiltrative pattern; prognostic factor

Indexed keywords

BCG VACCINE; EOSIN; EPIRUBICIN; HEMATOXYLIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER EPITHELIUM; CANCER GRADING; CANCER GROWTH; CANCER INFILTRATION; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE FREE SURVIVAL; ENDOPHYTIC GROWTH PATTERN; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; NON MUSCLE INVASIVE BLADDER CANCER; PROGNOSIS; STAINING; TRANSURETHRAL RESECTION; BLADDER TUMOR; PATHOLOGY; RETROSPECTIVE STUDY; UROTHELIUM;

AGED; FEMALE; HUMANS; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 79961121754     PISSN: None     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/1471-2490-11-17     Document Type: Article

References (17)

1. Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging. Sugano K, Kakizoe T, Nat Clin Pract Urol 2006 3 642 645 17149381
2. Subepithelial growth patterns in urothelial carcinoma-frequency and prognostic significance. Gofrit ON, Shapiro A, Pode D, Katz R, Yutkin V, Zorn KC, Pizov G, Urol Oncol 2010
3. Urothelial transitional cell carcinoma with endophytic growth patterns: a discussion of patterns of invasion and problems associated with assessment of invasion in 18 cases. Amin MB, Gámez JA, Young RH, Am J Surg Pathol 1997 21 1057 1068 10.1097/00000478-199709000-00010 9298882 (Pubitemid 27407290)
4. The prevalence and significance of Brunn's nests, cystitis cystica and squamous metaplasia in normal bladders. Wiener DP, Koss LG, Sablay B, Freed SZ, J Urol 1979 122 317 321 470001 (Pubitemid 10226071)
5. Management of transitional cell carcinoma involving von Brunn's nests. Dinney CP, Ramirez EI, Swanson DA, Ro JY, Babaian RJ, von Eschenbach AC, J Urol 1995 153 944 949, 1995 10.1016/S0022-5347(01)67610-9 7853580
6. Further observations on carcinoma in situ of the urinary bladder: silent but extensive intraprostatic involvement. Seemayer TA, Knaack J, Thelmo WL, Wang NS, Ahmed MN, Cancer 1975 36 514 520 10.1002/1097-0142(197508)36:2<514::AID- CNCR2820360230>3.0.CO;2-C 1157015
7. Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival. Jimenez RE, Gheiler E, Oskanian P, Tiguert R, Sakr W, Wood DP Jr, Pontes JE, Grignon DJ, Am J Surg Pathol 2000 24 980 987 10.1097/00000478-200007000-00009 10895820 (Pubitemid 30430485)
8. Histologic tumor growth pattern is significantly associated with disease-related survival in muscle-invasive transitional cell carcinoma of the urinary bladder. Krüger S, Noack F, Böhle A, Feller AC, Oncol Rep 2004 12 609 613 15289845
9. The effect of tumor invasion patterns on pathologic stage of bladder urothelial carcinomas. Bircan S, Candir O, Kapucuoglu N, Pathol Oncol Res 2005 11 87 91 10.1007/BF02893372 15999152 (Pubitemid 41039443)
10. Prognostic value of histopathological tumour growth patterns at the invasion front of T1G3 urothelial carcinoma of the bladder. Denzinger S, Burger M, Fritsche HM, Bertz S, Hofstädter F, Wieland WF, Hartmann A, Otto W, Scand J Urol Nephrol 2009 43 282 287 10.1080/00365590902854354 19382004
11. TNM classification of malignant tumors. Sobin LH, Wittekind C, eds, New York: John Wiley & Sons 6 2002
12. Histologic grading of noninvasive papillary urothelial neoplasms. MacLennan GT, Kirkali Z, Cheng L, Eur Urol 2007 51 889 897 10.1016/j.eururo. 2006.10.037 17095142 (Pubitemid 46281427)
13. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DW, Kurth K, Eur Urol 2006 49 466 475 10.1016/j.eururo.2005.12.031 16442208 (Pubitemid 43259554)
14. Bladder cancer. Barocas DA, Clark PE, Curr Opin Oncol 2008 20 307 314 10.1097/CCO.0b013e3282f8b03e 18391631 (Pubitemid 351507552)
15. Environmental factors promoting bladder cancer. Hirao Y, Kim WJ, Fujimoto K, Curr Opin Urol 2009 19 494 499 10.1097/MOU.0b013e32832eb4ef 19553820
16. Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T, Nat Rev Cancer 2005 5 744 749 10.1038/nrc1694 16148886 (Pubitemid 41486367)
17. Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors. Baumgart E, Cohen MS, Silva Neto B, Jacobs MA, Wotkowicz C, Rieger-Christ KM, Biolo A, Zeheb R, Loda M, Libertino JA, Summerhayes IC, Clin Cancer Res 2007 13 1685 1694 10.1158/1078-0432.CCR-06-2330 17363521 (Pubitemid 46952933)